Abstract:Objective To investigate the effects of Rapamycin, a mammalian target of rapamycin (mTOR) specific inhibitor, on the activation and growth of primordial follicles in mice from the signal transduction of follicular development. Methods A total of 40 C57BL/6 female mice were randomly divided into control group (n=20, same volume of saline) and Rapamycin treatment group (n=20, 5 mg/kg Rapamycin). Seven mice in each group were treated after 30 d, and ovarian histomorphological changes were observed by HE staining, the expressions of DDx4/MVH and Ki-67 were detected by immunohistochemistry, the level of mTOR and its downstream molecules were detected by Western blotting. Eight weeks after administration, 6 mice in control group and Rapamycin treatment group were selected for follicle count, and the expressions of anti-Mullerian hormone (AMH) and Ki-67 were detected by immunohistochemistry. Another 7 mice of both groups were treated with pregnant mare serum gonadotropin (PMSG) and human chorionic gonadotropin (hCG) for ovulation induction. The ovaries were obtained for histomorphological observation by HE staining. Results The number of primordial follicle in Rapamycin treatment group was significantly increased compared with control group (P=0.040), and a large number of primordial follicles were clustered, while the number of growing follicles was significantly decreased(P=0.002). The number of primordial follicle, expressing DDx4/MVH molecule, was increased, while the expression of Ki-67 was decreased compared with control group. Eight weeks after Rapamycin treatment, the number of primordial follicles was still more than that in control group, and the expressions of Ki-67 and AMH in growing follicles were normal. After ovulation induction treatment, large numbers of mature follicles or corpus luteum could be observed in both two groups. Western blotting showed that the phosphorylation levels of mTOR and its downstream molecules p70S6K, rpS6 and eIF4B in Rapamycin treated group were significantly lower than those in control group, while the total molecular level did not change significantly (P>0.05). Conclusion Rapamycin could inhibit the activation of primordial follicles by inhibiting the phosphorylation of mTOR signaling pathway, and slow down the transformation rate of primordial follicles to the growth follicles, and also inhibit the development of growing follicles, thus protect the ovarian reserve function.

Mammalian target of rapamycin/eukaryotic initiation factor 4F pathway regulates follicle growth and development of theca cells in mice.

Effects of Rapamycin on the Activation and Growth of Primordial Follicles in Mice

Rapamycin‐sensitive Mtorc1 Signaling is Involved in Physiological Primordial Follicle Activation in Mouse Ovary

Determination of mTOR signal pathway in MMTV-TGFα mice ovary at different ages

A Putative Mitotic Checkpoint Dependent on mTOR Function Controls Cell Proliferation and Survival in Ovarian Granulosa Cells

The effect of rapamycin treatment on mouse ovarian follicle development in dehydroepiandrosterone-induced polycystic ovary syndrome mouse model

mTOR is required for asymmetric division through small GTPases in mouse oocytes

MTOR-mediated interaction between the oocyte and granulosa cells regulates the development and function of both compartments in mice

Mtor/p70s6k Promotes Spermatogonia Proliferation and Spermatogenesis in Sprague Dawley Rats

Oocyte stage-specific effects of MTOR determine granulosa cell fate and oocyte quality in mice

[p53 regulates primordial follicle activation through the mTOR signaling pathway]

Inhibition of mTOR pathway decreases the expression of pre‐meiotic and meiotic markers throughout postnatal development and in adult testes in mice

Role of mTOR Signaling in Female Reproduction

MAPK3/1 participates in the activation of primordial follicles through mTORC1‐KITL signaling

CREB Activity is Required for Mtorc1 Signaling-Induced Primordial Follicle Activation in Mice

Distribution and association of mTOR with its cofactors, raptor and rictor, in cumulus cells and oocytes during meiotic maturation in mice

Rapamycin improves the quality and developmental competence of mice oocytes by promoting DNA damage repair during in vitro maturation

Rapamycin Maintains the Primordial Follicle Pool and Protects Ovarian Reserve Against Cyclophosphamide-Induced Damage

Successful Reversal of Ovarian Hyperstimulation Syndrome in a Mouse Model by Rapamycin, an Mtor Pathway Inhibitor

Restricting the induction of NGF in ovarian stroma engenders selective follicular activation through the mTOR signaling pathway

HDAC6 regulates primordial follicle activation through mTOR signaling pathway